Podcast series

This is an excellent educational and CPD resource for all.

The podcasts are great company for your commute to work or your dog walk, and really do make CPD interesting and easy!

In this inaugural episode Prof Christina Fotopoulou and Prof Sean Kehoe discuss the evidence surrounding surgery in ovarian cancer.

The SHAPE trial – a discussion with Dr Plante.  Dr Plante is Principal Investigator on the SHAPE study.

Professor Ranjit Manchanda discusses NICE guidance on identifying familial and genetic risk for ovarian cancer and delayed risk reducing surgery.

Welcome to the another BGCS podcast, where we explore the latest advances in gynecologic cancer care. Here is a brief introduction for the podcast on HIPEC in ovarian cancer, featuring Prof. WJ van Driel and Ms. Claire Thompson.

Welcome to this special episode of the BGCS podcast. Today, we’ll be discussing a critical advancement in the treatment of ovarian cancer—HIPEC (Hyperthermic Intraperitoneal Chemotherapy).  Joining us are two esteemed experts in this field: Prof. WJ van Driel, a renowned researcher and surgical oncologist from the Netherlands Cancer Institute, whose groundbreaking work on HIPEC has shaped clinical practice worldwide, and Ms. Claire Thompson, a leading Consultant Gynaecological Oncologist at the Mater Private Network in Dublin. Together, they will dive into how HIPEC is transforming outcomes for patients with ovarian cancer, offering hope in even the most challenging cases.

Today, in our episode before Christmas, I get the discuss the current challenges in cervical screening with Dr Tracie Miles (The Eve Appeal) and Dr Jen Davies (University of Manchester).

We talk all manner of things, from barriers to uptake both in the UK and in resource poor settings to urine based/non-invasive screening methods. We also highlight the best ways to communicate to patients in colposcopy and the areas of communication we often get wrong. Enjoy

Welcome to this special episode of the BGCS podcast, where we’re spotlighting one of the biggest events in the gynaecological cancer calendar – the British Gynaecological Cancer Society Annual Scientific Meeting 2025, taking place in just two weeks in the heart of London. We’re thrilled to be joined by two exceptional guests. First, Professor Ronny Drapkin, internationally renowned for his pioneering work identifying the fallopian tube as the origin of many high-grade serous ovarian cancers – a discovery that has fundamentally reshaped our understanding of this disease. And second, Professor Ranjit Manchanda, Chair of BGCS ASM 2025, who gives us a preview of what to expect at this year’s meeting – from cutting-edge science and surgical innovation, to global collaboration and the latest in prevention and early detection. Whether you’re a clinician, researcher, nurse specialist or trainee, this episode will get you excited for the science, the networking, and the vision driving progress in gynaecological oncology. Let’s dive in.